Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-90,277
Closed -$8.23M 1120
2022
Q2
$8.23M Sell
90,277
-384,335
-81% -$34.1M 0.09% 286
2022
Q1
$38.9M Buy
474,612
+218,208
+85% +$17.2M 0.3% 54
2021
Q4
$19.7M Buy
+256,404
New +$20.4M 0.17% 92
2019
Q2
Sell
-735,567
Closed -$58.4M 294
2019
Q1
$58.4M Buy
+735,567
New +$55M 0.35% 41
2015
Q1
Sell
-107,210
Closed -$5.81M 653
2014
Q4
$5.81M Buy
107,210
+34,902
+48% +$1.94M 0.02% 439
2014
Q3
$4.09M Buy
72,308
+58,164
+411% +$3.27M 0.01% 539
2014
Q2
$781K Buy
+14,144
New +$772K ﹤0.01% 684
2014
Q1
Sell
-58,793
Closed -$3.04M 791
2013
Q4
$2.81M Buy
+58,793
New +$2.69M 0.01% 615

Other funds holding MRK

Sculptor Capital's MRK Position: Q3 2022 in Review

Sculptor Capital sold out of Merck (MRK) in Q3 2022, closing a stake of 90,277 shares — an estimated $8.23M sold.

Sculptor Capital first reported a position in MRK in Q4 2013 and held it in 8 quarters. The position peaked at $58.4M in Q1 2019. 2,989 funds tracked by Wall St. Rank hold MRK as of Q3 2022.

  • Sculptor Capital reported no remaining Merck position as of Q3 2022 after selling out during the quarter.
  • Sculptor Capital sold 90,277 Merck shares in Q3 2022, an estimated $8.23M.
  • Sculptor Capital first reported a position in Merck in Q4 2013 and held it in 8 quarters.
  • Sculptor Capital's Merck position peaked at $58.4M in Q1 2019.
  • 2,989 funds tracked by Wall St. Rank held Merck as of Q3 2022.

Based on Sculptor Capital's 13F filing for Q3 2022, filed 14 Nov 2022.